Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

FR-208419: a new dual CCK-A and CCK-B/gastrin receptor antagonist

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Dec. 30, 1997

SAR leading to new topoisomerase I inhibitor presented by Banyu

Dec. 29, 1997

New AVP(4-9) analogue with beneficial effects on cognitive/memory deficits

Dec. 24, 1997

Mitsui presents new antipsychotic agent

Dec. 24, 1997

Efficacy of PR-000608 in mouse model of Parkinson's disease

Dec. 23, 1997

Mechanism of antiparkinsonian activity of KW-6002 explored in mice

Dec. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...